Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Recent Pat Anticancer Drug Discov ; 19(3): 257-267, 2024.
Article in English | MEDLINE | ID: mdl-37497702

ABSTRACT

Among the deadliest diseases, cancer is characterized by tumors or an increased number of a specific type of cell because of uncontrolled divisions during mitosis. Researchers in the current era concentrated on the development of highly selective anticancer medications due to the substantial toxicities of conventional cytotoxic drugs. Several marketed drug molecules have provided resistance against cancer through interaction with certain targets/growth factors/enzymes, such as Telomerase, Histone Deacetylase (HDAC), Methionine Aminopeptidase (MetAP II), Thymidylate Synthase (TS), Glycogen Synthase Kinase-3 (GSK), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Focal Adhesion Kinase (FAK), STAT3, Thymidine phosphorylase, and Alkaline phosphatase. The molecular structure of these drug molecules contains various heterocyclic moieties that act as pharmacophores. Recently, 1,3,4- oxadiazole (five-membered heterocyclic moiety) and its derivatives attracted researchers as these have been reported with a wide range of pharmacological activities, including anti-cancer. 1,3,4- oxadiazoles have exhibited anti-cancer potential via acting on any of the above targets. The presented study highlights the synthesis of anti-cancer 1,3,4-oxadiazoles, their mechanism of interactions with targets, along with structure-activity relationship concerning anti-cancer potential.


Subject(s)
Antineoplastic Agents , Neoplasms , Humans , Oxadiazoles/pharmacology , Oxadiazoles/therapeutic use , Vascular Endothelial Growth Factor A , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Molecular Structure , Structure-Activity Relationship , Neoplasms/drug therapy
2.
Small ; 20(9): e2307110, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37857577

ABSTRACT

Noble metal-based catalyst, despite their exorbitant cost, are the only successful catalyst for bifunctional oxygen electrocatalysis owing to their capability to drive forward the reaction rate kinetically. Therefore, it is desirable to diminish the noble metal loading without any compromise in the catalyst performance. In this study, the aim to achieve two goals with one action via a single-step route to have ultra-low loading of Pd in the catalyst. The Pd is used as a catalyst for C─C bond formation followed by complexation reactions or vice versa, in conventional Suzuki-Miyaura cross-coupling (SMCC) reaction, which yields a Pd-based porous organic polymer. Interestingly, it is found that dispersed Pd nanocluster (PdNC ) is present together with Pd single atom doped into nanocarbon (Pd-NC) matrix in the catalyst (PdNC /Pd-NC800 ) that obtained after pyrolysis of the porous polymer. The catalyst exhibits remarkable bifunctional activity and durability towards oxygen reduction reaction (ORR) and oxygen evolution reaction (OER). Further, it is studied that the in situ attenuated total reflection infrared (ATR-IR) spectroscopy at different electrochemical potentials during ORR and OER to observe the reaction intermediates. The homemade zinc-air battery with the catalyst displayed great performance, establishing the significance of PdNC /Pd-NC800 as a bifunctional oxygen electrocatalyst.

3.
Curr Org Synth ; 2023 Oct 24.
Article in English | MEDLINE | ID: mdl-37916627

ABSTRACT

BACKGROUND: Two significant families of compounds i.e. 1,3,4-oxadiazole and ben-zimidazole, have undergone extensive investigation into their pharmacological characteristics and possible therapeutic applications. Both classes have shown their potential in a variety of ap-plications, and because of their synergistic interactions, they may have an even better therapeutic impact when combined. OBJECTIVES: To produce a specific molecule with potent therapeutic properties, it is now common methods to combine at least two pharmacophores. This facilitates interaction with several targets, enhances biological functions, or eliminates adverse effects associated with them. CONCLUSION: The synthesis of benzimidazole-1,3,4-oxadiazole hybrid compounds has recently involved the use of several synthetic techniques, all of which are detailed in the literature along with the advantages and disadvantages. It has been noted that the structure-activity relationship relates their pharmacological actions to their molecular structure. In order to set the stage for future research, the study aims to provide researchers with an effective toolbox and an under-standing of benzimidazole and 1,3,4-oxadiazole hybrid compounds.

4.
Inorg Chem ; 62(33): 13519-13529, 2023 Aug 21.
Article in English | MEDLINE | ID: mdl-37562977

ABSTRACT

The development of affordable and non-noble-metal-based reversible oxygen electrocatalysts is required for renewable energy conversion and storage systems like metal-air batteries (MABs). However, the nonbifunctionality of most of the catalysts impedes their use in rechargeable MAB applications. Moreover, the loss of active sites also affects the long-term performance of the electrocatalyst toward oxygen electrocatalysis. In this work, we report a simplistic yet controllable chemical approach for the synthesis of dual transitional metals such as cobalt, nickel, and nitrogen-doped carbon (CoNi-NC) as bifunctional electrode materials for rechargeable zinc-air batteries (ZABs). The spatially isolated Ni-N4 and Co-N4 active units were rendered for oxygen reduction reaction (ORR) and oxygen evolution reaction (OER), respectively. The individual efficacy of both reversible reactions enables an ΔE value of ∼0.72 V, which outperforms several bifunctional electrocatalysts reported in the literature. The half-wave potential (E1/2) and overpotential were achieved at 0.83 V and 330 mV (vs RHE) for ORR and OER, respectively. The peak power density of ZAB equipped with the CoNi-NC catalyst was calculated to be 194 mW cm-2. The present strategy for the synthesis of bifunctional electrocatalysts with dual active sites offers prospects for developing electrochemical energy storage and conversion systems.

5.
Chem Biol Drug Des ; 102(4): 907-920, 2023 10.
Article in English | MEDLINE | ID: mdl-37277317

ABSTRACT

1,2,5-oxadiazole belongs to five-membered heterocyclic compounds with two nitrogen and one oxygen atom. In comparison with other heterocyclic moieties, 1,2,5-oxadiazoles moiety is considered as underprivileged as it attracted little attention of the researchers although lot of scopes and possible applications in medicinal, material and agriculture science. 1,2,5-oxadiazole and its derivatives have been reported as good pharmacophores as carbonic anhydrase inhibitors, antibacterial, vasodilating agents, antimalarial, anticancer, etc. In the presented manuscript, we reviewed granted patents and different synthetic strategies which have been reported for the synthesis of 1,2,5-oxadiazoles such as cycloaddition, dimerization, cyclodehydration, condensation, thermolysis, nitration, oxidation and ring-conversion. These synthetic methods have also been analysed for their merits and demerits. The manuscript also highlighted various applications of 1,2,5-oxadiazole and its derivatives. We hope that researchers across the scientific streams will be benefitted from the presented review articles for designing their work related to 1,2,5-oxadiazoles.


Subject(s)
Antimalarials , Oxadiazoles , Oxadiazoles/pharmacology , Carbonic Anhydrase Inhibitors , Antimalarials/pharmacology , Oxidation-Reduction , Structure-Activity Relationship
6.
Chem Commun (Camb) ; 58(36): 5506-5509, 2022 May 03.
Article in English | MEDLINE | ID: mdl-35419579

ABSTRACT

A new significant feature of a triazine-based covalent organic polymer electrocatalyst is demonstrated. The metal-free electrocatalyst has dual-active sites, which enable it to entangle oxygen via a push-pull interaction that plays a crucial role in promoting the oxygen reduction reaction.

SELECTION OF CITATIONS
SEARCH DETAIL
...